Menu

Reinsurance News

M&A environment still favourable for health insurers: AM Best

6th May 2021 - Author: Matt Sheehan

The environment for mergers and acquisitions (M&A) among U.S. health insurers remains favorable as they continue to seek out diversification and growth opportunities, according to analysts at AM Best.

medical-and-health-claimsThe rating agency noted in a recent report that health insurers reported record earnings and accumulated a significant amount of cash in 2020.

They also have maintained a heightened appetite for debt amid the prolonged, historically low interest rates in the credit markets.

According to AM Best, beyond traditional M&A activity there has been a notable trend of increasing vertical integration and diversifying into other health services business.

Insurers have been focusing on technology advancements and the entire health care delivery process to make their operations more efficient, including urgent care clinics, hospice facilities, wholesale distributors, provider practices and pharmacy benefit managers (PBM).

AM Best observed that these service capability businesses help to better manage medical costs and also generally have higher margins.

“These initiatives aim to improve patient outcomes, create efficiencies, manage medical expenditures, improve coordination of care, increase access and address gaps in care,” said Jason Hopper, associate director, industry research & analytics at AM Best.

However, prescription drug costs have been a driver of rising costs for health insurers, far outpacing hospital and outpatient costs with expenses rising by more than 4% between 2010 and 2016.

That said, in more recent years, prescription drug expenses have held steady since as fewer new high-priced drugs have come to market.

“The flattening of prescription drug expenses has resulted in a decline in prescription drugs as a share of total benefits paid,” said Bridget Maehr, associate director.

“Although fewer high-cost drugs have come to market in recent years, health insurers are still looking to their PBMs to manage overall spending on pharmaceuticals, especially for specialty drugs.”

AM Best’s analysis shows that some companies have found affiliations to be a better solution than M&A when it comes to eliminating administrative costs and gaining efficiencies.

Affiliations allow larger carriers to leverage their investments in technology, but also provide smaller companies with advanced data analytics and customized solutions that would normally be too expensive for them to implement.

Print Friendly, PDF & Email

Recent Reinsurance News

Getting your daily reinsurance news from Reinsurance News is a simple way to receive only the reinsurance industry news that matters, delivered directly to your email inbox.

  • Only email is mandatory, but the more you tell us about yourself the better we can serve you in future!
  • This field is for validation purposes and should be left unchanged.

By submitting the form you are giving your consent to be emailed by us.

Read previous post:
COVID-19 uncertainty remains a key risk for 2021: Munich Re CFO

While the global vaccination effort is enabling parts of the world to open up and providing people with vital protection...

Close